Member Info for ALIBZ

Total number of He1 new shares issued May to October

From HE1 RNS during the period, listed by RNS date, shareholder, number of shares and value received for CLN finance, the following can be put together….

29th May 2025 5,921,426,896

30th May 2025 added 1,341,463 new ordinary shares

Company's issued share capital will consist of 5,922,768,359 ordinary shares

Result of Oversubscribed WRAP Retail Offer 07 August 2025

185,185,185

Company's issued ordinary share capital will consist of 6,404,091,962 Ordinary Shares

The number of shares added corresponds to approximately 30% of the share issue from the He1 RNS released since May....

Notice of Conversion of Advance 29 August 2025

410,714,286 new Ordinary Shares for £1,725,000

total number of Ordinary Shares and voting rights in the Company will be 7,014,526,636

Notice of Conversion of Advance 24 September 2025

702,127,658 new Ordinary Shares for £ 1,650,000

total number of Ordinary Shares and voting rights in the Company will be 7,716,654,294

Final Conversion and Termination of Investment Agreement 13 October 2025

1,605,504,587 new Ordinary Shares for £3,500.00

total number of Ordinary Shares and voting rights in the Company will be 9,322,158,881

Total number of shares received for CLN = 2,718,346,531

CLN funds £10,000,000

CLN funds received £7,875,000

CLN funds returned including interest £2,380,000

Net CLN funds received = £7,620,000

Total number of shares received for £7,620,000 = 2,718,346,531

Percentage of He1 increased number of shares = 29.16% - presumably owned by the "3 known investors" - and an RNS showing their stakes will arrive asssuming that they didn't forward sell all their CLN allocated shares...

The increase in number of shares between 29th May and 13th October = 3,400,731,985 representing a 63.7% increase in the number of shares in He1.

Presumably £7,620,000 for a 29.16% stake in He1 is good value for money if the investors, who have not been identified and, so far, have not triggered an RNS to indicate that they have passed a threshold requiring that their shareholding is made public. Maybe a valuation of £26,132,000 would represent a good value for the investors in He1 against the increased shares in circulation.

Maybe an expert can shed a little light on some rough calculations? Thanks 😊😊😊

Hi Sinitta, posted the following - apparently no interest in the numbers picked out from the BB.

Hope they are of interest to you. All the Best

Prompted by the question... has anyone crunched the numbers...

Total number of He1 new shares issued May to October

From HE1 RNS during the period, listed by RNS date, shareholder, number of shares and value received for CLN finance, the following can be put together….

29th May 2025 5,921,426,896

30th May 2025 added 1,341,463 new ordinary shares

Company's issued share capital will consist of 5,922,768,359 ordinary shares

Result of Oversubscribed WRAP Retail Offer 07 August 2025

185,185,185

Company's issued ordinary share capital will consist of 6,404,091,962 Ordinary Shares

Notice of Conversion of Advance 29 August 2025

410,714,286 new Ordinary Shares for £1,725,000

total number of Ordinary Shares and voting rights in the Company will be 7,014,526,636

Notice of Conversion of Advance 24 September 2025

702,127,658 new Ordinary Shares for £ 1,650,000

total number of Ordinary Shares and voting rights in the Company will be 7,716,654,294

Final Conversion and Termination of Investment Agreement 13 October 2025

1,605,504,587 new Ordinary Shares for £3,500.00

total number of Ordinary Shares and voting rights in the Company will be 9,322,158,881

Total number of shares received for CLN = 2,718,346,531

CLN funds £10,000,000

CLN funds received £7,875,000

CLN funds returned including interest £2,380,000

Net CLN funds received = £7,620,000

Total number of shares received for £7,620,000 = 2,718,346,531

Percentage of He1 increased number of shares = 29.16%

The increase in number of shares between 29th May and 13th October = 3,400,731,985 representing a 63.7% increase in the number of shares in He1.

Presumably £7,620,000 for a 29.16% stake in He1 is good value for money if the investors, who have not been identified and, so far, have not triggered an RNS to indicate that they have passed a threshold requiring that their shareholding is made public. Maybe a valuation of £26,132,000 would represent a good value for the investors in He1 against the increased shares in circulation.

Maybe an expert can shed a little light on some rough calculations? Thanks 😊😊😊

Prompted by the question... has anyone crunched the numbers...

Total number of He1 new shares issued May to October

From HE1 RNS during the period, listed by RNS date, shareholder, number of shares and value received for CLN finance, the following can be put together….

29th May 2025 5,921,426,896

30th May 2025 added 1,341,463 new ordinary shares

Company's issued share capital will consist of 5,922,768,359 ordinary shares

Result of Oversubscribed WRAP Retail Offer 07 August 2025

185,185,185

Company's issued ordinary share capital will consist of 6,404,091,962 Ordinary Shares

Notice of Conversion of Advance 29 August 2025

410,714,286 new Ordinary Shares for £1,725,000

total number of Ordinary Shares and voting rights in the Company will be 7,014,526,636

Notice of Conversion of Advance 24 September 2025

702,127,658 new Ordinary Shares for £ 1,650,000

total number of Ordinary Shares and voting rights in the Company will be 7,716,654,294

Final Conversion and Termination of Investment Agreement 13 October 2025

1,605,504,587 new Ordinary Shares for £3,500.00

total number of Ordinary Shares and voting rights in the Company will be 9,322,158,881

Total number of shares received for CLN = 2,718,346,531

CLN funds £10,000,000

CLN funds received £7,875,000

CLN funds returned including interest £2,380,000

Net CLN funds received = £7,620,000

Total number of shares received for £7,620,000 = 2,718,346,531

Percentage of He1 increased number of shares = 29.16%

The increase in number of shares between 29th May and 13th October = 3,400,731,985 representing a 63.7% increase in the number of shares in He1.

Presumably £7,620,000 for a 29.16% stake in He1 is good value for money if the investors, who have not been identified and, so far, have not triggered an RNS to indicate that they have passed a threshold requiring that their shareholding is made public. Maybe a valuation of £26,132,000 would represent a good value for the investors in He1 against the increased shares in circulation.

Maybe an expert can shed a little light on some rough calculations? Thanks 😊😊😊

Glitch on apparent share price on iWeb... 145p 🤣😂🙄 made this LTH double take -shares still suspended and think the writing is on the wall in the RNS- no activity to report, burning whatever cash systematically until it runs out and delisting dates and timetable now there for shareholder approval! Astounding that nothing can be done with the licence to trade bitcoin after the resurgence during the last couple of years.

Here's hoping for some explanations and the board to deliver something of value for their shareholders. Think I'll see if I can fine a creek to paddle in... Oh, sorry wrong lost paddle??? GLA

OK, it's a repost... but nice to see that an institutional investor wants part of Shield (1.9%) as of 12th September. Not to large dilution and a wider shareholder base is positive news. "Unsolicited approach"....

From the RNS today:

This placing is in the best interests of the Company by broadening its institutional shareholder base and whilst we remain confident in turning cash flow positive by the end of 2025 it also further strengthens the Company's working capital position allowing the Board and management to focus completely on accelerating sales of ACCRUFeR

Will be interesting when Q3 and Q4 results become available. PI's and long term holders will be really looking forward to the cash flow positive milestone, this year!

Think PRO_TRADER is correct in that 2-3 years will be the time to see how Shield has progressed providing they are given the time. GLA

A bid would be fantastic, although aren't AOP a majority shareholder and do not need approval for their bid if they decided to take over the Shield?

Think there was some initial agreement that they wouldn't launch a hostile bid during one of the previous funding rounds, not sure if the agreement is permanent (in which no hostile bid can be made - unlikely) or if there was any agreement with Shield over the time limit.

Given the history for raising funds through a discaounted share subscription the news about reaching cashflow positive/breakeven due by the end of Q4 2025 will no doubt have a significant effect on the share price going into 2026... GLA

Message for Chris Baraniuk - BBC Technology of Business reporter... in the interest of balanced and informative public service broadcasting...

"Hi Chris, I enjoyed reading your article on the BBC website about new sustainable approaches to making ammonia and the potential for green ammonia as a source of hydrogen.

Do you know about the UK company that already has an ammonia cracker trial operating to produce green hydrogen?

Quite surprised that there was no mention of AFC, I have copied a link to the company news page.

https://www.afcenergy.com/news

I think that it could be of additional UK interest to your your article:

https://www.bbc.co.uk/news/business-68230697

Kind regards.... "

Looking at the spreads and timing to : 13:48

About 570,00 buys

Unknown 250,000 at 8:49:50 = the sell...

Shows that you cannot always never really trust the information on this website!

apart from the nonesense trades for the 20 and 31 shares in blue....

Sorry, that should have been "posted as sells" :-)

Also, if all "buys" are being sold as "sells" it does create a very false impression.

Not sure why the share price is at 6.20 when you can but at 6.1 now and could buy at 6.19 at 8:00am!!!?

Seems as though someone hasn't updated the share price correctly....

Interesting observation about TB and coat tails... so a good time to buy could be now - TB has found current prices attractive?

Announced Traded Action Notifier Price Currency Amount Holding

16-Jan-23 13-Jan-23 Buy Trevor Brown 8.00 GBX 350,000 13,199,424

19-Dec-22 16-Dec-22 Buy Trevor Brown 9.00 GBX 250,000 12,849,424

07-Nov-22 04-Nov-22 Buy Trevor Brown 7.99 GBX 170,000 12,599,424

11-Jul-22 08-Jul-22 Buy Trevor Brown 12.00 GBX 25,000 5,071,920

11-Jul-22 08-Jul-22 Buy Trevor Brown 11.50 GBX 50,000 5,071,920

For a large dividend which some posters would like to see soon - need a sale from BRH portfolio, and the timing?

Maybe it will occur when the science and business case is ready.... and maybe after the grant of options and vested shares have been taken up?

The incentive scheme has been used to lower the share price of the share options in March during 2022 and 2023....

RNS Number : 8123K cancellation of directors purchase at 31.5p re-issued at 14p on 9 May 2022

RNS Number : 2333U On 14 October 2021, options were granted over 1,500,000 and 2,000,000 Ordinary Shares to Trevor Brown (CEO) and Vivian Hallam (Executive Director) respectively, at an exercise price of 31.5p per share

So remaining options from 14 October 2021 cancelled and

new options granted

In aggregate, 2,900,000 Options have been granted to Directors of the Company

The Options granted to Vivian Hallam are EMI options and the Options granted to Trevor Brown, Susan Hagan and Qu Li are unapproved options. The exercise price of the Options is 7.75p, being the closing mid-market price of an Ordinary Share on 24 March 2023, the date of grant. The Options will vest from 27 March 2024 and be exercisable up to 27 March 2033, subject to continued employment. The Options granted to Trevor Brown and Vivian Hallam, as Executive Directors of the Company, have an additional performance related vesting criteria that the closing mid-market price of an Ordinary Share must exceed 9.6875p (being a 25% premium to the Option exercise price) for 10 business days out of a consecutive 30 business day period.

So maybe sometime after 24th March and later in 2024 might become notable dates for BRH II's...

GLA to the long term investors

Reading back through earlier posts... 7:09am today....

"When I arrived at the Company 5-6 years ago, we were fairly little known other than amongst a small circle of clients that we’d been working with for a while. " from Laura2022?

So presume - Laura2022 is a Physiomics employee with plenty of knowledge!???